Robenacoxib |CAS 220991-32-2|DC Chemicals

Cas No.:	220991-32-2
Chemical Name:	Robenacoxib
Synonyms:	Benzeneacetic acid,5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]-;Robenacoxib;2-[5-ethyl-2-(2,3,5,6-tetrafluoroanilino)phenyl]acetic acid;Robenacoxib-D5;5-Ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]benzeneacetic acid;CGS 34975;Onsior;J-014494;robenacoxibum;(5-Ethyl-2-((2,3,5,6-tetrafluorophenyl)amino)phenyl)acetic acid;Z588009C7C;ROBENACOXIB [MI];ROBENACOXIB (EMA EPAR VETERINARY);AKOS040747410;5-ethyl-2-(2', 3', 5', 6'-tetrafluoroanilino)phenylacetic acid;MFCD27966869;CHEMBL2107774;C20708;2-(5-Ethyl-2-((2,3,5,6-tetrafluorophenyl)amino)phenyl)acetic acid;CGS-34975;5-ethyl-2-(2',3',5',6'-tetrafluoroanilino) phenylacetic acid;5-ethyl-2-(2',3',5', 6'-tetrafluoroanilino)phenylacetic acid;Robenacoxib [INN];DB11455;NCGC00532515-01;Q7341121;{5-ethyl-2-[(2,3,5,6-tetrafluorophenyl)amino]phenyl}acetic acid;DTXSID90176607;DTXCID3099098;onsior Tablets for Cats;onsior injection;UNII-Z588009C7C;CHEBI:76269;SCHEMBL6036596;A902615;5-ethyl-2-(2',3',5',6'-tetrafluoroanilino)phenylacetic acid;BCP23758;HY-118078;ROBENACOXIB [EMA EPAR VETERINARY];FT-0674451;220991-32-2;NS00068133;ZEXGDYFACFXQPF-UHFFFAOYSA-N;CS-0065148;5-ethyl-2-(2', 3',5',6'-tetrafluoroanilino)phenylacetic acid;ROBENACOXIB [GREEN BOOK]
SMILES:	C(C1=CC(CC(O)=O)=C(NC2C(F)=C(F)C=C(F)C=2F)C=C1)C
Formula:	C₁₆H₁₃NO₂F₄
M.Wt:	327.27352
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Robenacoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine for the relief of pain and inflammation in cats and dogs, a Cyclooxygenase(COX)-1 and COX-2 inhibitor.

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.